VABIOTECH
- Company typePrivate
- Founded2000
- HeadquartersHanoi, Vietnam
- Headcount1–10
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
VABIOTECH firmographics
Firmographics- Name
- VABIOTECH
- Legal name
- Công ty TNHH MTV Vắc xin và Sinh phẩm số 1
- Website
- https://vabiotech.com.vn
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
VABIOTECH industry classification
Industry- Product category
- Vaccine Manufacturing
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Travel & Tropical Disease Vaccines (HLAIAEAE)
- akta.pro secondary industries
- Vaccines & Cold-Chain Pharmaceutical Distributors (HLAIAJAG), Vaccine Fill-Finish, Packaging & Cold-Chain Formulation (vial/syringe, lyophilization, thermostable) (HLAAAEAJ)
Keywords
Where VABIOTECH is headquartered
LocationHeadquarters
- HQ city
- Hanoi
- HQ country
- Vietnam
- HQ region
- Asia
Offices3 records
Markets served
VABIOTECH business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Infrastructure, Supply Chain, Operations, Marketing or Sales
Revenue model
- Vaccine Manufacturing and Sales: Domestic production and sale of four vaccine types (Hepatitis A, Hepatitis B, Japanese Encephalitis, Oral Cholera) to government procurement, healthcare facilities, and the Expanded Immunization Programme. Revenue is generated through bulk supply contracts with the Ministry of Health and public health channels. In 2025, produced 6.54 million domestic doses and consumed over 10 million total doses.
- Imported Vaccine Distribution: Import and distribution of vaccines manufactured by international partners, including combination vaccines (DPT-VGB-Hib), MMR, rabies, pneumococcal, meningococcal, varicella, and blood products (albumin, IVIg). Revenue generated through commercial distribution channels.
- Vaccination Services: Direct vaccination service provision through VABIOTECH Care clinics offering routine immunizations, travel vaccinations, and seasonal flu shots. Revenue from service fees charged to individuals and organizations at two clinic facilities.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
VABIOTECH product offering
Product offeringCore offering
VABIOTECH is a state-owned vaccine and biological products manufacturer under Vietnam's Ministry of Health, domestically producing four vaccine types (Hepatitis A – HAVAX®, Recombinant Hepatitis B – Gene-HBvax, Japanese Encephalitis – JEVAX®, and Oral Cholera – mORCVAX) using cell culture, recombinant DNA, and plasma fractionation technologies. The company also imports and distributes vaccines and blood-derived products from international manufacturers, and operates two VABIOTECH Care vaccination clinics in Hanoi offering routine, travel, and seasonal immunizations directly to consumers.
Product overview
VABIOTECH operates as a state-owned vaccine and biological products manufacturer under Vietnam's Ministry of Health, producing four domestically manufactured vaccines (HAVAX®, Gene-HBvax, JEVAX®, mORCVAX) while also importing and distributing vaccines from international manufacturers. The company provides vaccination services through its VABIOTECH Care centers and is developing several new vaccines currently under registration, including Varicella, HPV, Hand Foot and Mouth Disease, Rabies (RABIVAX-S), and Pneumococcal vaccines. The product portfolio spans hepatitis vaccines, Japanese encephalitis vaccine, cholera vaccine, and upcoming vaccines targeting chickenpox, cervical cancer, hand-foot-mouth disease, rabies, and pneumococcal infections.
Differentiator
Problem solved
Functional benefit
Brands
- VABIOTECH Care: Vaccination services brand offering routine immunizations, travel vaccinations, and seasonal vaccinations. Operates vaccination centers at Mac Thai Tong Facility and Thang Long International Village Facility.
Products and services
- HAVAX® Hepatitis A vaccine manufactured by VABIOTECH for protection against Hepatitis A virus infection, supplied to Vietnam's Expanded Immunization Programme.
- Gene-HBvax Recombinant Hepatitis B vaccine produced using recombinant DNA technology for Hepatitis B virus protection, supplied to the national immunization program.
- JEVAX® Japanese Encephalitis vaccine manufactured domestically for protection against Japanese Encephalitis virus transmitted by mosquitoes, supplied to the EPI.
- mORCVAX Oral cholera vaccine produced domestically for protection against cholera infection.
- VABIOTECH Care Vaccination Services Comprehensive vaccination services including routine immunizations for children and adults, travel vaccinations, and seasonal flu shots, offered directly to individual consumers at two facilities in Hanoi under the VABIOTECH Care brand.
- Imported vaccine distribution (DPT-VGB-Hib, MMR, rabies, pneumococcal, meningococcal VA-MENGOC-BC, varicella) Import and distribution of vaccines manufactured by international partners, including the DPT-VGB-Hib 5-in-1 combination vaccine, MMR, rabies, pneumococcal, meningococcal (VA-MENGOC-BC), and varicella vaccines, supplied through commercial channels and the EPI.
- Blood-derived biological products (Albumin, IVIg) Plasma fractionation-derived biological products including Albumin and intravenous immunoglobulin (IVIg) for clinical use in healthcare facilities.
Quantifiable outcome
- Supplied over 3.6 million doses of domestically manufactured vaccines to the Expanded Immunization Programme in 2025.
- +2 more outcomes
Companies that use VABIOTECH
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
VABIOTECH technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
VABIOTECH partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered minor and core.
- Australian Universities (via Ministry of Health Delegation)minorA Vietnamese Ministry of Health delegation, including VABIOTECH, conducted meetings with Australian universities in June 2026 to strengthen cooperation in medical training and advanced technology applications in healthcare.
- World Health Organization (WHO)coreVABIOTECH collaborates with WHO on vaccine quality standards, regulatory guidance, and international vaccine technology frameworks. WHO serves as a key reference body for VABIOTECH's manufacturing quality and prequalification efforts.
- UNICEFcoreUNICEF is a key global procurement partner for vaccines supplied by VABIOTECH, facilitating access to international vaccine markets and supporting supply chain logistics for the national immunization program.
- Gavi, the Vaccine AlliancecoreGavi supports Vietnam's immunization program and partners with VABIOTECH on vaccine introduction, supply security, and introduction of new vaccines into the national program.
- International Vaccine Institute (IVI)minorVABIOTECH collaborates with IVI on vaccine research, development, and technology transfer for vaccine candidates of international public health importance.
- Korea International Cooperation Agency (KOICA)minorKOICA partners with VABIOTECH through Korean government development cooperation programs supporting healthcare infrastructure and vaccine technology advancement in Vietnam.
- Japan International Cooperation Agency (JICA)minorJICA supports capacity building and technology cooperation with VABIOTECH, including training and technology transfer in vaccine manufacturing quality standards.
- Serum Institute of IndiacoreSerum Institute of India is a key international supplier whose vaccines are imported and distributed by VABIOTECH in Vietnam, including DPT combination and other pediatric vaccines.
- Bill & Melinda Gates FoundationminorThe Gates Foundation supports global health initiatives that may involve VABIOTECH's vaccine programs and technology advancement efforts through funding and technical assistance.
- National Institute of Hygiene and Epidemiology (NIHE) / Viện Vệ sinh Dịch tễ Trung ươngcoreVABIOTECH originated as a unit under NIHE. The company maintains a close operational and research relationship with NIHE as a key government research institution in epidemiology and vaccine development.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
VABIOTECH competitors and assessment
Company assessmentDirect peers
- Bharat Biotech: Indian vaccine manufacturer with a comparable emerging-market focus, broad vaccine portfolio (hepatitis, JE, cholera, rotavirus), and similar government-channel positioning. Operates at a larger scale but mirrors VABIOTECH's tropical disease vaccine focus.
- Finlay Vaccine Institute (Cuba): State-owned Cuban vaccine manufacturer — closely comparable to VABIOTECH in ownership structure (government), emerging-market focus, and WHO/UNICEF partnership profile. VABIOTECH distributes Finlay's VA-MENGOC-BC meningococcal vaccine in Vietnam.
- Biological E: Indian vaccine and biologics manufacturer listed among VABIOTECH's international partners, with comparable product breadth in routine pediatric and combination vaccines. Direct channel and product overlap.
- SK Bioscience: South Korean vaccine developer and manufacturer partnered with VABIOTECH. Comparable in technology platforms (cell culture, recombinant) and target on government immunization programs and emerging disease vaccines.
- Serum Institute of India: World's largest vaccine manufacturer by doses; directly comparable as a high-volume emerging-market producer supplying WHO/Gavi/UNICEF channels. VABIOTECH is also a distribution partner and importer of Serum Institute products in Vietnam.
Broad incumbents
- GSK Vaccines: Global vaccine incumbent covering most of VABIOTECH's therapeutic areas (hepatitis A/B, HPV, pneumococcal). Represents the global standard that VABIOTECH must compete with or partner around for WHO prequalification.
- Sanofi Pasteur: Global vaccine major and broad incumbent in the same product categories (hepatitis, JE, cholera, rabies). Represents both a potential technology partner and competitive threat as it expands emerging-market presence.
Emerging players
- Panacea Biotec: Indian vaccine manufacturer with overlapping focus on pediatric combination vaccines (DPT, polio, hepatitis) supplied through UNICEF and government channels. Comparable emerging-market vaccine manufacturer profile.
- Hualan Biological Engineering: Chinese vaccine and plasma-derived biologics manufacturer with comparable focus on hepatitis, flu, and plasma fractionation. Similar portfolio breadth to VABIOTECH and regional emerging-market supplier profile.
Regional players
- China National Biotec Group (CNBG / Sinopharm): China's largest state-owned vaccine and biologics manufacturer — closely comparable to VABIOTECH in ownership structure, regulatory positioning, and emerging-market export focus, though at substantially greater scale.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
VABIOTECH social profiles
Digital presenceVABIOTECH financial estimates
Financial estimateRevenue estimate
Valuation estimate
VABIOTECH leadership team
Management profileNumber of profiles
Profiles1 record
VABIOTECH funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
VABIOTECH M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about VABIOTECH
What does VABIOTECH do?
VABIOTECH is a state-owned vaccine and biological products manufacturer under Vietnam's Ministry of Health, domestically producing four vaccine types (Hepatitis A – HAVAX®, Recombinant Hepatitis B – Gene-HBvax, Japanese Encephalitis – JEVAX®, and Oral Cholera – mORCVAX) using cell culture, recombinant DNA, and plasma fractionation technologies. The company also imports and distributes vaccines and blood-derived products from international manufacturers, and operates two VABIOTECH Care vaccination clinics in Hanoi offering routine, travel, and seasonal immunizations directly to consumers.
Is VABIOTECH a public or private company?
VABIOTECH is a private company. It is classified as state government owned and is currently operating.
When was VABIOTECH founded?
VABIOTECH was founded in 2000. It employs 1 to 10 people.
Where is VABIOTECH based?
VABIOTECH is headquartered in Hanoi, Vietnam, in the Asia region.
How does VABIOTECH make money?
Three revenue lines are on record. Vaccine Manufacturing and Sales are the primary driver. The others are imported Vaccine Distribution and vaccination Services.
Who are VABIOTECH's main competitors?
Direct peers on record are Bharat Biotech, Finlay Vaccine Institute (Cuba), Biological E, SK Bioscience and Serum Institute of India. Broad incumbents are GSK Vaccines and Sanofi Pasteur. Emerging players are Panacea Biotec and Hualan Biological Engineering. China National Biotec Group (CNBG / Sinopharm) is listed as a regional player.
Does VABIOTECH have an API?
No public API is recorded for VABIOTECH.
What industry is VABIOTECH in?
VABIOTECH's product category is Vaccine Manufacturing. Its primary akta.pro industry code is HLAIAEAE, Travel & Tropical Disease Vaccines, with a secondary code of HLAIAJAG, Vaccines & Cold-Chain Pharmaceutical Distributors. Its NAICS code is 325414 and its SIC code is 2836.